CompletedNCT01772485
Official study titleDouble Blind Randomized Controlled Trial Evaluation of a Novel Brain Plasticity-based Training Program for the Remediation of Cognitive Deficits in Adolescents With ADHD in New Delhi, India
This study has finished and is no longer accepting participants.
In New DelhiADHDBehavioural studyAges 11–17
- Countries
- India
- Sponsor
- Posit Science Corporation
CompletedNCT00191880
Official study titleA Phase IIIb Open-Label Trial of Atomoxetine Hydrochloride to Evaluate Academic Outcome in Children Ages 8 to 11 Years With Attention-Deficit/Hyperactivity Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including CalgaryADHDMedication studyAges 8–11
- Countries
- Canada
- Sponsor
- Eli Lilly and Company
CompletedNCT02215538
Official study titleConcerta in the Treatment of Adult ADHD and a Comparison of Four Adult ADHD Scales and Effects on Personality
This study has finished and is no longer accepting participants.
In Salt Lake CityADHDMedication studyAges 18–65
- Countries
- United States
- Sponsor
- University of Utah
CompletedNCT03957993
Official study titlePilot Study: Addressing Home-Based Functional Challenges Via Telehealth-Based Occupational Therapy
This study has finished and is no longer accepting participants.
In CincinnatiADHDInterventional studyAges 4–18
- Countries
- United States
- Sponsor
- Children's Hospital Medical Center, Cincinnati
CompletedNCT00916786
This study has finished and is no longer accepting participants.
In TaipeiADHDObservational studyAges 7–18
- Countries
- Taiwan
- Sponsor
- National Taiwan University Hospital
CompletedNCT01907360
Official study titleA Phase I/II, Single Center, Single-Treatment, Open-Label, Adaptive Clinical Trial Design Examining the Pharmacokinetic Effects of up to Two Separate HLD200 Modified Release Formulations of Methylphenidate in Adolescent and Pediatric Subjects With ADHD
This study has finished and is no longer accepting participants.
In Las VegasADHDMedication studyAges 6–17
- Countries
- United States
- Sponsor
- Ironshore Pharmaceuticals and Development, Inc
CompletedNCT02286817
What is this study about?This study evaluated the safety and effectiveness of NFC-1 for people with ADHD.
This study has finished and is no longer accepting participants.
In PhiladelphiaADHDMedication studyAges 12–17
- Countries
- United States
- Sponsor
- Aevi Genomic Medicine, LLC, a Cerecor company
Active Not RecruitingNCT07647900
Official study titlePhotography-Based Intervention to Improve Emotion Wellbeing and Symptoms in Children With Attention Deficit Hyperactivity Disorder
This study is no longer accepting new participants.
In Hong KongADHDBehavioural studyAges 8–12
- Countries
- China
- Sponsor
- The Hong Kong Polytechnic University
CompletedNCT07231354
Official study titleThe Role of Physiotherapy in the Mental Health of Children and Adolescents With Neurodevelopmental Disorders: A Randomized Controlled Trial
This study has finished and is no longer accepting participants.
In ThessalonikiADHDBehavioural studyAges 6–18
- Countries
- Greece
- Sponsor
- International Hellenic University
CompletedNCT00573534
Official study titlePilot Study of Vyvanse™ (Lisdexamfetamine Dimesylate) in Adolescents (Ages 11-15) With ADHD and an Older Sibling With ADHD and Substance Dependence
This study has finished and is no longer accepting participants.
Location not clearly listedADHDMedication studyAges 11–15
- Countries
- Sponsor
- New York State Psychiatric Institute
TerminatedNCT03942835
Official study titlePsychometric Validation of the Competitive Attention Test (CAT) : Simultaneous and Separated Measures of Voluntary and Involuntary Attention
This study ended early.
In BronADHDInterventional studyAges 6–90
- Countries
- France
- Sponsor
- Hospices Civils de Lyon
CompletedNCT02217371
Official study titleRole of Circadian and Homeostatic Systems in the Regulation of Wakefulness in Adult Patients With Attention Deficit Disorder With or Without Hyperactivity
This study has finished and is no longer accepting participants.
In BordeauxADHDInterventional studyAges 18–50
- Countries
- France
- Sponsor
- University Hospital, Bordeaux